MUMBAI, India, Aug. 31 -- Intellectual Property India has published a patent application (202617081598 A) filed by Eli Lilly And Company; and Atrium Therapeutics, Inc. on July 02, 2026, for Compositions And Methods For Modulating Nav1.8.
Inventors include Boyles, Jeffrey; Bhattacharya, Arvind Pctus No; Brown-Augsburger, Patricia; Cochran, Michael Caramian; Davies, Julian; Hobbs, Wendy Loza Application Number; Kwan, Yu Yan; Matalonga Borrel, Jonatan; Mcdermott, Jeff S. Number; Oliva Detanico, Thiago; and Wall, Christopher Earle.
The application for the patent was published on August 28, 2026, under issue no. 35/2026.
Abstract: The present disclosure is related to oligonucleotides, antibody-siRNA conjugates, or pharmaceutical compositions thereof for inhibiting the expression of Nav1.8 gene and methods of using such oligonucleotides, antibody-siRNA conjugates, or pharmaceutical compositions thereof in reducing/treating pain or diseases/disorders related toNav1.8.
Disclaimer: Curated by HT Syndication.
